Stereotactic centralized ablative radiation therapy: a framework for ultra-heterogeneous radiotherapy of bulky tumors - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Stereotactic Ablative Radiation Therapy: A New Approach for Treating Complex Bulky Tumors

  • By

  • Jun Yang

  • Weisi Yan

  • Qiuxia Lu

  • Weihua Qi

  • Junqi Song

  • Liangfu Han

  • Waleed F. Mourad

  • Jiyuan Yang

  • Xiaodong Wu

  • July 1, 2026

Share

  • 1

    Stereotactic Centralized Ablative Radiation Therapy (SCART) is proposed for treating bulky tumors that challenge conventional radiotherapy methods.

  • 2

    SCART focuses on delivering an ablative dose to a central treatment volume while preserving normal tissue around the tumor.

  • 3

    The SCART framework includes a core-to-periphery dose ratio and a steep dose gradient to enhance treatment efficacy.

  • 4

    SCART is intended for patients with bulky tumors ≥5 cm, where surgery is not feasible and conventional radiotherapy is limited.

  • 5

    Early clinical experience suggests SCART's technical feasibility, but further prospective studies are needed to validate its effectiveness.

Original Source(s)

Stereotactic centralized ablative radiation therapy: a framework for ultra-heterogeneous radiotherapy of bulky tumors

  • by Jun Yang, Weisi Yan, Qiuxia Lu, Weihua Qi, Junqi Song, Liangfu Han, Waleed F. Mourad, Jiyuan Yang, Xiaodong Wu

  • July 1, 2026

Related Content

Circadian rhythms in the tumor microenvironment: spatiotemporal immune regulation and chronotherapeutic opportunities

Survival Outcomes in ERBB2- Low vs ERBB2- Null Advanced Gastric Cancer

Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eµ-TCL1 mice